Key Takeaways Eli Lilly plans to invest at least $27 billion to build four new pharmaceutical manufacturing sites in the ...
Eli Lilly, the maker of blockbuster weight loss and diabetes drugs Zepbound and Mounjaro, said it will invest an additional ...
Eli Lilly (LLY) stock in focus as company boosts U.S. medicine production investment to $50B, creating 3,000 skilled jobs & ...
Eli Lilly has acquired Organovo’s lead asset, a clinical FXR agonist designed to treat inflammatory bowel disease (IBD), in a ...